JP2023512631A - Ｈｂｖ特異的ｔｃｒライブラリーおよび個別化医療としてのその使用 - Google Patents

Ｈｂｖ特異的ｔｃｒライブラリーおよび個別化医療としてのその使用 Download PDF

Info

Publication number
JP2023512631A
JP2023512631A JP2022543767A JP2022543767A JP2023512631A JP 2023512631 A JP2023512631 A JP 2023512631A JP 2022543767 A JP2022543767 A JP 2022543767A JP 2022543767 A JP2022543767 A JP 2022543767A JP 2023512631 A JP2023512631 A JP 2023512631A
Authority
JP
Japan
Prior art keywords
seq
tcrs
library
hla
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022543767A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023512631A5 (https=
Inventor
アントニオ ベルトレッティ、
ツィ ツォン ホ、
セレン コー、
アンソニー、 タノト タン、
ル－エン ワイ、
Original Assignee
ライオン ティーシーアール プライベート リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライオン ティーシーアール プライベート リミテッド filed Critical ライオン ティーシーアール プライベート リミテッド
Publication of JP2023512631A publication Critical patent/JP2023512631A/ja
Publication of JP2023512631A5 publication Critical patent/JP2023512631A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/15—Natural-killer [NK] cells; Natural-killer T [NKT] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/31—Chimeric antigen receptors [CAR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/32—T-cell receptors [TCR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Developmental Biology & Embryology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
JP2022543767A 2020-01-21 2021-01-21 Ｈｂｖ特異的ｔｃｒライブラリーおよび個別化医療としてのその使用 Pending JP2023512631A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2020/051439 WO2021148110A1 (en) 2020-01-21 2020-01-21 Hbv specific tcr library and its use as personalised medicine
EPPCT/EP2020/051439 2020-01-21
PCT/EP2021/051356 WO2021148547A1 (en) 2020-01-21 2021-01-21 Hbv specific tcr library and its use as personalised medicine

Publications (2)

Publication Number Publication Date
JP2023512631A true JP2023512631A (ja) 2023-03-28
JP2023512631A5 JP2023512631A5 (https=) 2024-01-24

Family

ID=69187789

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022543767A Pending JP2023512631A (ja) 2020-01-21 2021-01-21 Ｈｂｖ特異的ｔｃｒライブラリーおよび個別化医療としてのその使用

Country Status (7)

Country Link
US (1) US20230061817A1 (https=)
EP (1) EP4093759A1 (https=)
JP (1) JP2023512631A (https=)
KR (1) KR20220148809A (https=)
CN (1) CN115335397A (https=)
TW (1) TW202140534A (https=)
WO (2) WO2021148110A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110156889B (zh) * 2018-02-14 2023-03-10 中国科学院广州生物医药与健康研究院 高亲和力HBs T细胞受体
US20250273289A1 (en) * 2024-02-23 2025-08-28 Tata Consultancy Services Limited Insilico method and system for designing a baseline peptide bioreceptor for sensing a biomarker for dysglycemic disorders
CN121319150B (zh) * 2025-12-16 2026-04-14 温州医科大学 一种同时识别hbv核心抗原表位及包膜蛋白表位的tcr及其编码序列

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009136874A1 (en) * 2008-05-09 2009-11-12 Agency For Science, Technology And Research Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof
WO2018056897A1 (en) * 2016-09-23 2018-03-29 Lion Tcr Pte. Ltd. An hbv antigen specific binding molecules and fragments thereof
JP2019506154A (ja) * 2016-01-06 2019-03-07 ヘルス リサーチ インコーポレイテッドＨｅａｌｔｈ Ｒｅｓｅａｒｃｈ， Ｉｎｃ． 組換えｔ細胞受容体を含む組成物及びライブラリー並びに組換えｔ細胞受容体を使用する方法
JP2019509753A (ja) * 2016-03-31 2019-04-11 ライオン ティーシーアール ピーティーイー．エルティーディー． 外因性ウイルス特異的ｔ細胞受容体（ｔｃｒ）を発現する非活性化ｔ細胞

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009136874A1 (en) * 2008-05-09 2009-11-12 Agency For Science, Technology And Research Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof
JP2019506154A (ja) * 2016-01-06 2019-03-07 ヘルス リサーチ インコーポレイテッドＨｅａｌｔｈ Ｒｅｓｅａｒｃｈ， Ｉｎｃ． 組換えｔ細胞受容体を含む組成物及びライブラリー並びに組換えｔ細胞受容体を使用する方法
JP2019509753A (ja) * 2016-03-31 2019-04-11 ライオン ティーシーアール ピーティーイー．エルティーディー． 外因性ウイルス特異的ｔ細胞受容体（ｔｃｒ）を発現する非活性化ｔ細胞
WO2018056897A1 (en) * 2016-09-23 2018-03-29 Lion Tcr Pte. Ltd. An hbv antigen specific binding molecules and fragments thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GLANVILLE, J., ET AL.: ""Identifying specificity groups in the T cell receptor repertoire."", NATURE, vol. 547, JPN6025006208, 6 July 2017 (2017-07-06), pages 94 - 98, ISSN: 0005529970 *
WAGNER, E.K., ET AL.: ""Human cytomegalovirus-specific T-cell receptor engineered for high affinity and soluble expression", J. BIOL. CHEM., vol. 294, no. 15, JPN6025006209, 22 February 2019 (2019-02-22), pages 5790 - 5804, ISSN: 0005682877 *

Also Published As

Publication number Publication date
TW202140534A (zh) 2021-11-01
EP4093759A1 (en) 2022-11-30
WO2021148110A1 (en) 2021-07-29
KR20220148809A (ko) 2022-11-07
WO2021148547A1 (en) 2021-07-29
CN115335397A (zh) 2022-11-11
US20230061817A1 (en) 2023-03-02

Similar Documents

Publication Publication Date Title
US11596654B2 (en) Human leukocyte antigen restricted gamma delta T cell receptors and methods of use thereof
KR102804498B1 (ko) 입양 세포 치료를 위한 방법 및 조성물
AU2017330379B2 (en) Generation and use in adoptive immunotherapy of stem cell-like memory T cells
KR20230017194A (ko) 키메라 항원 수용체를 발현하는 바이러스 특이적 면역 세포를 사용한 동종반응의 치료 및 예방
CN116041538A (zh) 修饰的嵌合受体及相关组合物和方法
JP2023512631A (ja) Ｈｂｖ特異的ｔｃｒライブラリーおよび個別化医療としてのその使用
JP2024515803A (ja) キメラ抗原受容体を発現するウイルス特異的免疫細胞
EP4536695A1 (en) Hbv surface antigen specific t cell receptors and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240116

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250218

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250515

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250909